Results 11 to 20 of about 3,733 (171)
Topical decongestants in otorhinolaryngologist practice
Медицинский совет, 2021 The problem of long-term and uncontrolled use of decongestants remains one of the most relevant problems of modern otorhinolaryngology. To date vasoconstrictors are the most actively used drugs for the treatment of acute and chronic rhinitis, as well as ...
A. A. Krivopalov, P. A. Shamkina
doaj +1 more source
The Indispensable Nasal Decongestant: Patients’ Views and Perspectives on Nasal Decongestant Overuse
The Journal of Allergy and Clinical Immunology: In Practice, 2023 Rhinitis medicamentosa (RM) is a type of nonallergic rhinitis caused by prolonged use of nasal decongestants (NDs). Although it is a preventable phenotype of rhinitis, little is known about patients dealing with this condition.To gain a better understanding of patients' views and experiences of ND overuse, and potential facilitators and barriers to ...
Sophie Scheire +6 more
openaire +2 more sources
Long-acting topical decongestants
Медицинский совет, 2020 Significant role of getting the required amount of air into the human body belongs to the breathing by the nose. The nasal cavity prepares the air for reciprocity with the lower respiratory tract owing to the complex structure of the mucous membrane ...
A. Yu. Ovchinnikov +3 more
doaj +1 more source
CURRENT ASPECTS OF USE OF NASAL VASOCONSTRICTORS AND ADJUNCTIVE AGENTS IN PEDIATRIC PRACTICE
Медицинский совет, 2018 Nasal forms of vasoconstrictor agents (decongestants) are one of the most frequently prescribed groups of drugs in the therapy of inflammatory diseases of the nasal cavity.
D. A. Tulupov +3 more
doaj +1 more source
Update on the efficiency and safety of orally administered nasal decongestants [PDF]
Romanian Journal of Infectious Diseases, 2023 Nasal congestion leading to obstruction is one of the main symptoms in acute rhinosinusitis (common cold), other upper respiratory infections and allergic rhinitis. The EPOS 2020 guidelines place oral decongestants as an efficient therapy for the relief
Victoria Arama +4 more
doaj +1 more source
Management of hypertrophic rhinitis by application of Kadali kshara: An observation
Journal of Ayurveda Case Reports, 2023 Nasal obstruction is a predominant symptom in hypertrophied inferior turbinate. It can be understood as Nasanaha (~nasal obstruction) in Ayurveda. Even though there are many conditions of the nose causing nasal blockage; inferior turbinate hypertrophy ...
A. Anjali, K. Sivabalaji, B. N. Ashwini
doaj +1 more source
Brazilian Journal of Pharmaceutical Sciences, 2011 Nasal decongestants in Brazil are available without prescription. They are one of the most requested medications in Brazil. The use of nasal decongestants, however, may lead to serious consequences.
Dominik Lenz +3 more
doaj +1 more source
Acute Rhinosinusitis in Children: a Place of Nasal Decongestants in the Treatment of the disease
Zdorovʹe Rebenka, 2016 The article presents current data on acute rhinosinusitis, its essence, classification, etiology, pathogenesis, treatment approaches in children.
H.V. Beketova
doaj +1 more source
Bengal Journal of Otolaryngology and Head Neck Surgery, 2020 Introduction Nasal decongestants are one of the drugs commonly prescribed by otorhinolaryngologists in their day to day practice. The excessive or inappropriate use of nasal decongestant due to rapid symptomatic relief leads to drug misuse or abuse ...
Valli Rajasekaran, Puja Ghosh
doaj +1 more source
Treating acute rhinitis and exacerbations of chronic rhinitis – A role for topical decongestants?
South African Family Practice, 2020 Acute nasal symptoms are troublesome for patients. In addition, these symptoms are encountered frequently by individuals because of common infectious diseases, especially rhinovirus, giving rise to a ‘common cold’.
Robin J. Green +5 more
doaj +1 more source